NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Stupp, Roger, Wong, Eric T., Kanner, Andrew A., Steinberg, David, Engelhard, Herbert, Heidecke, Volkmar, Kirson, Eilon D., Taillibert, Sophie +27 more·2012·European Journal of Cancer

Cited by (862)

Items 501–600 of 862

  1. Computational simulations establish a novel transducer array placement arrangement that extends delivery of therapeutic TTFields to the infratentorium of patients with brainstem gliomas
    Marigdalia K. Ramirez-Fort, Ariel Naveh, Shearwood McClelland, Casey K. Gilman, Migdalia Fort, Melissa Mendez, Jaime Matta, Ze’ev Bomzon, Christopher S. Lange · 2021 · Reports of Practical Oncology & Radiotherapy
  2. Tumor-treating fields in combination with sorafenib curtails the growth of colorectal carcinoma by inactivating AKT/STAT3 signaling
    Eun Ho Kim, Won Seok Lee, Hoon Kyu Oh · 2022 · Translational Cancer Research
  3. An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma
    Garni Barkhoudarian, Michael Badruddoja, Nicholas Alfred Blondin, Sajeel A. Chowdhary, Charles Cobbs, J. Paul Duic, John Paul Flores, Ekokobe Fonkem, Edward Francis McClay, Burt Nabors et al. · 2023 · CNS Oncology
  4. HIGH GRADE GLIOMAS
    A. Leonard, Johannes Ernst Alexander Wolff, R. Sengupta, J. Marassa, D. Piwnica-Worms, J. Rubin, Ian Pollack, Regina I. Jakacki, Lisa Helene Butterfield, Hideho Okada et al. · 2012 · Neuro-Oncology
  5. Resolution of Cystic Enhancement to Add-On Tumor Treating Electric Fields for Recurrent Glioblastoma after Incomplete Response to Bevacizumab
    Grace Elzinga, Eric T. Wong · 2014 · Case Reports in Neurology
  6. Continuous Time Random Walk and Migration–Proliferation Dichotomy of Brain Cancer
    Alexander Iomin · 2014 · Biophysical Reviews and Letters
  7. The Practical Application of Emerging Technologies Influencing the Diagnosis and Care of Patients With Primary Brain Tumors
    Leland Hu, Daniel Jay Brat, Orin G. Bloch, Shakti H Ramkissoon, Glenn Jay Lesser · 2020 · American Society of Clinical Oncology Educational Book
  8. A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults
    Patrick Roth, Andreas Felix Hottinger, Thomas Hundsberger, Heinz Philipp Laubli, Philippe Schucht, Michael Reinert, Christoph Mamot, Ulrich Roelcke, Gianfranco Angelo Pesce, Silvia Höfer et al. · 2020 · Swiss Medical Weekly
  9. Tumor treating fields for newly diagnosed high‐grade glioma based on the criteria of 2021 WHO CNS5: A retrospective analysis of Chinese patients in a single center
    L. Zhang, Yanming Ren, Youheng Peng, Yong Luo, Yan‐Hui Liu, Xiang Wang, Yuan Yang, Lei Liu, Ping Ai, Xiaoyan Yang et al. · 2024 · Cancer Medicine
  10. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy
    Marlon Garzo Saria, Santosh Kesari · 2016 · Clinical journal of oncology nursing
  11. Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022
    Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes · 2023 · Expert Opinion on Drug Discovery
  12. Improving glioblastoma treatment with imaging, radiotherapy, drug delivery, and therapeutic systems
    Katarzyna Mnich, Stéphanie Lhomond, Eimear J. Wallace, Pierre‐Jean Le Reste, Abhay S. Pandit, Éric Chevet, Clare Reidy, Afshin Samali A, Garry P. Duffy, Adrienne M. Gorman · 2025 · Device
  13. Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series
    John Ross Crawford, Marlon Garzo Saria, Girish Dhall, Ashley Margol, Santosh Kesari · 2020 · Cureus
  14. Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma
    Adithya Balasubramanian, Ashray Gunjur, Umbreen Hafeez, Siddharth Menon, Lawrence Cher, Sagun Parakh, Hui Kong Gan · 2020 · Neuro-Oncology Advances
  15. Lessons learned from contemporary glioblastoma randomized clinical trials through systematic review and network meta-analysis: part 2 recurrent glioblastoma
    Shervin Taslimi, Vincent Chen Ye, Patrick Yung Wen, Gelareh Mohammed Zadeh · 2021 · Neuro-Oncology Advances
  16. The Role of Medicinal Mushrooms in Brain Cancer Therapies: Review
    Maria Letizia Gargano, Giuseppe Venturella, Filippo Bosco, Maria Grazia Fabrini, Wenyuan Gao, Lorenzo Pecoraro · 2021 · International journal of medicinal mushrooms
  17. Clinical outcomes of dose-escalated re-irradiation in patients with recurrent high-grade glioma
    Corbin A. Helis, Shih-Ni Prim, Christina Kehl Cramer, Roy Ervin Strowd III, Glenn Jay Lesser, Jaclyn J. White, Stephen B. Tatter, Adrian W. Laxton, Christopher T. Whitlow, Hui‐Wen Lo et al. · 2022 · Neuro-Oncology Practice
  18. Brain Invasion and Trends in Molecular Research on Meningioma
    Kyeong-O Go, Young Zoon Kim · 2023 · Brain Tumor Research and Treatment
  19. How I treat glioblastoma in older patients
    Nimish A. Mohile · 2015 · Journal of Geriatric Oncology
  20. Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial
    Younèss Nour, Christoph Pöttgen, Sied Kebir, Lazaros Lazaridis, Lutz Lüdemann, Maja Guberina, Thomas Christoph Gauler, Björn Scheffler, Ramazan Jabbarli, Daniela Pierscianek et al. · 2021 · Journal of Applied Clinical Medical Physics
  21. Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy
    Aaron D. Skolnik, Sumei Wang, Pallavi P. Gopal, Suyash Mohan · 2018 · Frontiers in Neurology
  22. Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review
    Quintino Giorgio D’Alessandris, Grazia Menna, Alessandro Izzo, Manuela D’Ercole, Giuseppe Maria Della Pepa, Liverana Lauretti, Roberto Pallini M. D, Alessandro Olivi, Nicola Montano · 2023 · International Journal of Molecular Sciences
  23. Real-world experience with TTFields in glioma patients with emphasis on therapy usage
    Claudius Jelgersma, Joan Alsolivany, Gülsüm Akkas, David Wasilewski, Bastian Gastl, Martin Misch, David Capper, David Kaul, Lars Bullinger, Peter Vajkoczy et al. · 2025 · Frontiers in Oncology
  24. Invasive and non-invasive tumor-treating electric field (TTF) therapy: An exciting advance in oncologic neuromodulation
    Thomas Eckert, Rishishankar E. Suresh, M. S. Zobaer, Nathan Christopher Rowland · 2025 · Brain stimulation
  25. Glioblastoma: From Pathophysiology to Novel Therapeutic Approaches
    Anatevka Ribeiro, Gianna Fote, Alexander Scott Himstead, Michelle Zheng, Emma Elliott, Sara Mae Smith, Jerry J. Lou, Carlen Yuen · 2025 · Biomedicines
  26. Ion channels as molecular targets of glioblastoma electrotherapy
    Tayeb Abed, Katrin Ganser, Franziska Eckert, Nicolai Stransky, Stephan M. Huber · 2023 · Frontiers in Cellular Neuroscience
  27. Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas
    Hao‐Wen Sim, Selena Lorrey, Mustafa Khasraw · 2023 · Current Neurology and Neuroscience Reports
  28. Advances in gene therapy for high-grade glioma: a review of the clinical evidence
    Matthew Goldman, Alexandra M. Baskin, Martyn A. Sharpe, David S. Baskin · 2024 · Expert Review of Neurotherapeutics
  29. Health-related quality of life in patients with progressive glioblastoma treated with combined bevacizumab and lomustine versus lomustine only: Secondary outcome of the randomized phase III EORTC 26101 study
    Linda Dirven, Abigirl Machingura, Martin J. van den Bent, Corneel Coens, Andrew Bottomley, Alba Ariela Brandes, Julien Dômont, Ahmed Idbaïh, Johan A F Koekkoek, Jaap C. Reijneveld et al. · 2024 · Neuro-Oncology Practice
  30. Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi Study
    Warren P. Mason, Rebecca Anne Harrison, Sarah Lapointe, Mary Jane Lim-Fat, Mary Valeria MacNeil, David Mathieu, James Perry, Marshall W. Pitz, David Roberge, Derek S. Tsang et al. · 2025 · Current Oncology
  31. Malignant Glioma with Primitive Neuroectodermal Components: Clinical and Pathologic Features with Treatment Modalities of Five Cases
    Tara Kimbason, Scott Turner, Syed Aj Kazmi · 2015 · Journal of Clinical & Experimental Pathology
  32. Apoptosis and cell cycle arrest of hepatocellular carcinoma spheroids treated by an alternating electric field
    Chun‐Hao Huang, Kin Fong Lei, Ngan‐Ming Tsang · 2019 · Biotechnology Progress
  33. Prospective comparative study of intraoperative balloon electronic brachytherapy versus resection with multidisciplinary adjuvant therapy for recurrent glioblastoma
    А. Л. Кривошапкин, Alekey S. Gaytan, Orkhan Abdullaev, Nidal Salim, Сергеев Глеб Сергеевич, Ilya Marmazeev, Evaldas Cesnulis, Tim Killeen, Vladimir Tyuryn, Roman Kiselev et al. · 2021 · Surgical Neurology International
  34. Multiple subtentorial metastasis in diffuse midline glioma receiving tumor treating fields: a case report and literature review
    Chaofeng Liang, Jin Gong, Baoyu Zhang, Zhan’ao Meng, Manting Li, Ying Guo · 2021 · Annals of Translational Medicine
  35. Technical note: Evaluation of methods for reducing edge current density under electrode arrays for tumor‐treating fields therapy
    Heehun Sung, Yunhui Jo, Geon Oh, Yongha Gi, Hyun‐Woo Kim, Sangmin Park, Jaehyeon Seo, Myonggeun Yoon · 2022 · Medical Physics
  36. Multi-Arm GlioblastoMa Australasia (MAGMA): protocol for a multiarm randomised clinical trial for people affected by glioblastoma
    Benjamin Y. Kong, Hao‐Wen Sim, Elizabeth Helen Barnes, Anna K. Nowak, Elizabeth Jane Hovey, Rosalind L. Jeffree, Rosemary Anne Harrup, Jonathon Parkinson, Hui Kong Gan, Mark Blayne Pinkham et al. · 2022 · BMJ Open
  37. Brain and Human Body Modelling 2021
    Sergey N. Makarov, Gregory M. Noetscher, Aapo R. Nummenmaa · 2022 · Springer eBooks
  38. The role of immune subtyping in glioma mRNA vaccine development
    Alexandro Guterres, Mayla Abrahim Costa, Patrícia Neves · 2023 · Immunotherapy
  39. Gold-gold sulfide nanoshell as a novel intensifier for anti-tumor effects of radiofrequency fields.
    Hamid Reza Sadeghi, Mohammad Hossein Bahreyni-Toosi, Naser Tayebi Meybodi, Habibollah Esmaily, Samaneh Soudmand, Hossein Eshghi, Samaneh Soudmand, Ameneh Sazgarnia · 2014 · PubMed Central
  40. The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review
    Jan Gaertner, Vera Weingärtner, Stefan Lange, Elke Hausner, Ansgar Gerhardus, Steffen T. Simon, Raymond Voltz, Gerhild Becker, Norbert Schmacke · 2015 · PLoS ONE
  41. Molecular-Based and Alternative Therapies for Pancreatic Cancer
    Renée M. Tholey, Janet A. Sawicki, Jonathan Robert Brody · 2012 · The Cancer Journal
  42. Treatment of Gliomas: A Changing Landscape
    Lia Moriguchi Halasz, Scott G. Soltys, John C. Breneman, Michael David Chan, Nadia N. Issa Laack, Giuseppe Caracciolo Minniti, John P. Kirkpatrick · 2017 · International Journal of Radiation Oncology*Biology*Physics
  43. Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study
    Catherine R. García, Stacey A. Slone, Rachael M. Morgan, Lindsey Gruber, Sameera S. Kumar, Donita D. Lightner, John Lee Villano · 2018 · Medical Oncology
  44. Complete radiological response following subtotal resection in three glioblastoma patients under treatment with Tumor Treating Fields
    Almuth Friederike Kessler, Thomas Linsenmann, Thomas Westermaier, Wanja Wolber, Judith Weiland, Camelia‐Maria Monoranu, Maria Breun, Carsten Hagemann, Ralf‐Ingo Ernestus, Mario L�hr · 2019 · Oncology Letters
  45. Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses
    Francesco Schettini, Estela Pineda, Andrea Rocca, Victoria Buché, Carmine Antonio Donofrio, Manuel Mazariegos, Benvenuto Ferrari, Richard J. Tancredi, Stefano Panni, Marika Cominetti et al. · 2024 · The Oncologist
  46. Advancement in tumor treating fields of mechanism, clinical applications, and future directions
    Meiqi Zang, Song Zhu, Qiang Niu · 2025 · Discover Oncology
  47. Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastoma
    Hasan Alrefai, Benjamin Lin, Amr Elkholy, Manoj Kumar, Taylor L. Schanel, Kevin J. Lee, Patricia H. Hicks, Joshua Charles Anderson, Gao Guo, Eun-Young Erin Ahn et al. · 2025 · Acta Neuropathologica Communications
  48. The algorithms of adjuvant therapy in gliomas and their effect on survival
    Christoph Straube, Friederike Schmidt‐Graf, Benedikt Wiestler, Claus Zimmer, Bernhard Meyer, Stephanie Elisabeth Combs · 2019 · Journal of Neurosurgical Sciences
  49. Stereotactic radiosurgery for recurrent high-grade gliomas
    Trent Shane Kite, Vineetha Yadlapalli, John Herbst, Stephen Karlovits, Rodney E. Wegner, Matthew J. Shepard · 2025 · Journal of Clinical Neuroscience
  50. Tumor-Treating Fields and Related Treatments in the Management of Pediatric Brain Tumors
    Julien Rousseau, Sarah Lapointe, David Roberge · 2025 · Current Oncology
  51. Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities
    Amber B. Jones, Taylor L. Schanel, Mikayla R. Rigsby, Corinne E. Griguer, Braden C. McFarland, Joshua Charles Anderson, Christopher Douglas Willey, Anita B. Hjelmeland · 2023 · Cells
  52. Electric fields for the treatment of glioblastoma
    Pasquale DE BONIS, Francesco Doglietto, Carmelo Anile, Angelo Pompucci, Annunziato Mangiola · 2012 · Expert Review of Neurotherapeutics
  53. Dendritic cell vaccination for glioblastoma multiforme: review with focus on predictive factors for treatment response
    Steven De Vleeschouwer, Joost Dejaegher, Stefaan Van Gool · 2014 · ImmunoTargets and Therapy
  54. Tumour Treating Fields (TTFs) for recurrent and newly diagnosed glioblastoma multiforme.
    Farhan Arshad Mirza, Muhammad Shahzad Shamim · 2018 · PubMed
  55. Tumor-Treating Fields at EMBC 2019: A Roadmap to Developing a Framework for TTFields Dosimetry and Treatment Planning
    Zéev Bomzon, Cornelia Wenger, Martin Andreas Proescholdt, Suyash Mohan · 2020 · Springer eBooks
  56. Physical approaches to treat glioblastoma
    Sofiya Latifyan, Rita De Micheli, Andreas Felix Hottinger · 2020 · Current Opinion in Oncology
  57. Tumor Treating Fields : Additional Mechanisms and Additional Applications
    Ashwin Kumaria · 2021 · Journal of Korean Neurosurgical Society
  58. A narrative review on the management of glioblastoma in China
    Ming-Juan Zhao, Taojunjing Lu, Chao Ma, Xinghuan Wang, Zhiqiang Li · 2022 · Chinese Clinical Oncology
  59. Postmortem study of organ-specific toxicity in glioblastoma patients treated with a combination of temozolomide, irinotecan and bevacizumab
    Guangrong Lu, Ping Zhu, Mayank Rao, Nadine Linendoll, Louis Maximilian Buja, Meenakshi B. Bhattacharjee, Robert Eldon Brown, Leomar Y. Ballester, Xuejun Tian, Monika E. Pilichowska et al. · 2022 · Journal of Neuro-Oncology
  60. Tumor Treating Fields—An Emerging Cancer Treatment Modality
    Mary Elizabeth Davis · 2013 · Clinical journal of oncology nursing
  61. Recent Updates in the Treatment of Glioblastoma: Introduction
    Minesh P. Mehta, Steven S. Brem · 2014 · Seminars in Oncology
  62. Treatment for Patients With Newly Diagnosed Glioblastoma—Reply
    Roger Stupp, Steven A. Toms, Santosh Kesari · 2016 · JAMA
  63. Impact of tumor-treating fields on the survival of Japanese patients with newly diagnosed glioblastoma: A multicenter, retrospective cohort study
    Masayuki Kanamori, Shunsuke Tsuzuki, Ichiyo Shibahara, Kuniaki Saito, Yoshiteru Shimoda, Kazuhiro Tanaka, Shigeru Yamaguchi, Manabu Natsumeda, Tomoo Matsutani, Mitsuto Hanihara et al. · 2024 · Neuro-Oncology Advances
  64. Tumor Treating Fields (TTFields) Therapy in Unresectable Pleural Mesothelioma: Overview of Efficacy, Safety, and Future Outlook
    Giovanni Luca Ceresoli, Letizia Gianoncelli · 2025 · Current Treatment Options in Oncology
  65. Stereotactic radiosurgery for recurrent high-grade gliomas: a systematic review
    Trent Shane Kite, Bryce Bossinger, Vineetha Yadlapalli, Stephen Jaffee, John Herbst, Stephen Karlovits, Rodney E. Wegner, Matthew J. Shepard · 2025 · Journal of Neuro-Oncology
  66. Optimized Image-Based Surrogate Endpoints in Targeted Therapies for Glioblastoma: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
    Chong Hyun Suh, Ho Sung Kim, Seung Chai Jung, Choong Gon Choi, Sang Joon Kim, Kyung Won Kim · 2020 · Korean Journal of Radiology
  67. Tumor treating fields combined with a poly (adenosine diphosphate-ribose) polymerase inhibitor during radiotherapy for rapidly progressing IDH-wildtype diffuse astrocytoma: a case report
    Zheng Wang, Yi Ren, Fangfang Du, Yafang Sun, Wei Jiang · 2021 · Journal of International Medical Research
  68. Histologic Findings at the Time of Repeat Resection Predicts Survival in Patients with Glioblastoma
    Kaitlyn F. Melnick, Patricia Miller, Ethan Carmichael, Yu Wang, David Dinh Tran, Jesse Lee Kresak, Ashley Parham Ghiaseddin, Maryam Rahman · 2022 · World Neurosurgery
  69. Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis
    Xue Du, Chunbao Chen, Xiao Yu, Yu Cui, Lu Yang, Xiaochun Li, Xueping Liu, Ruisi Wang, Bangxian Tan · 2022 · Frontiers in Oncology
  70. Redox in Cancer Metabolism: Manipulation of Cancer Metabolism Through Exploitation of Redox Environments
    Craig McBeth · 2023 · ChemElectroChem
  71. Tumor treating fields suppress tumor cell growth and neurologic decline in models of spinal metastases
    Daniel Ledbetter, Rômulo Augusto Andrade de Almeida, Xizi Wu, Ariel Naveh, Chirag B. Patel, Queena Gonzalez, Thomas Hendrix Beckham, Robert Y. North, Laurence D. Rhines, Jing Li et al. · 2024 · JCI Insight
  72. “Tumor Treating Fields” delivered via electromagnetic induction have varied effects across glioma cell lines and electric field amplitudes
    Rea Ravin, Teddy X. Cai, Aiguo Li, Nicole Briceno, Randall H. Pursley, Marcial Garmendia-Cedillos, Tom Pohida, Herui Wang, Zhengping Zhuang, Jing Cui et al. · 2024 · American Journal of Cancer Research
  73. Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study
    INTERVAL-GB Collaborative, Conor Scott Gillespie, Emily Rose Bligh, Michael T. C. Poon, Abdurrahman I. Islim, Georgios Solomou, Melissa Gough, Christopher Paul Millward, Ola Rominiyi, Rasheed Zakaria et al. · 2024 · Journal of Neuro-Oncology
  74. Outcomes of symptomatic compared to asymptomatic recurrences in patients with glioblastoma multiforme (GBM)
    Arya Amini, Basel Altoos, Sana D. Karam, Timothy V. Waxweiler, Chad G. Rusthoven, Laurie E. Gaspar, Justin Morris Honce, Denise M. Damek, Douglas Edward Ney, David Ryan Ormond et al. · 2015 · Journal of Radiation Oncology
  75. Co-Culturing Cancer Cells and Normal Cells in a Biochip under Electrical Stimulation
    Kin Fong Lei, Shao-Chieh Hsieh, Rei‐Lin Kuo, Ngan‐Ming Tsang · 2018 · BioChip Journal
  76. What is New in Neuro-oncology?
    Jigisha P. Thakkar, Vikram C. Prabhu, Katherine B. Peters, Rimas Vincas Lukas · 2020 · Neurologic Clinics
  77. Clinical Trials in Glioblastoma — Designs and Challenges
    Helen J. Madsen, Justin E. Hellwinkel, Michael W. Graner · 2015 · InTech eBooks
  78. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
    Mercedes M. Riley, Pyay San, Edwin Lok, Kenneth D. Swanson, Eric T. Wong · 2019 · Journal of Visualized Experiments
  79. A Roundtable Discussion on the Clinical Challenges and Options for the Treatment of Glioblastoma: Introducing a Novel Modality, TTFields
    Nicholas Arthur Butowski, Eric T. Wong, Minesh P. Mehta, Lydia K. Wilson · 2013 · Seminars in Oncology
  80. Tumor-Treating Fields—A Fundamental Change in Locoregional Management for Glioblastoma
    Isabella Zhang, Jonathan P.S. Knisely · 2016 · JAMA Oncology
  81. Investigating an alternative ring design of transducer arrays for tumor treating fields (TTFields)
    Mario Macedo, Cornelia Wenger, Ricardo Salvador, Sofia Rita Fernandes, Pedro Cavaleiro Miranda · 2016 · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)
  82. Overview of pathology and treatment of primary brain tumours
    Herbert B. Newton, Ekokobe Fonkem · 2022 · Elsevier eBooks
  83. Long-Term Survival in Hepatocellular Carcinoma following Second-Line Tumor Treating Fields Therapy and Sorafenib: A Case Report
    Marisa Torres Velasco, Rafael Álvarez-Gallego, Paloma Peinado, Cesar Gregorio Muñoz, Lisardo Ugidos, Marcial García-Morillo, Emilio Vicente, Yolanda Quijano, Susana Prados, Enrique de la Fuente et al. · 2024 · Case Reports in Oncology
  84. Multiomics Insights into the Mechanism and Enhanced Efficacy of Tumor Treating Fields (TTFields) Therapy in Glioblastoma
    Yanmei Gao, Chenxu Wang, Guobin Liu, Ruilin Zhang, Xuelian Ren, Guangyuan Hu, Qi Mei, He Huang · 2025 · Journal of Proteome Research
  85. Novel Therapies in Oncology: An Individualized Approach
    Stephanie Gregory, Margaret Kelley, Tanya Lalani · 2021 · AACN Advanced Critical Care
  86. Characteristics and management of tumor treating fields-related dermatological complications in patients with glioblastoma
    Chao Yang, Qing Rong Zhang, Chao Ma, Yong Huang, Haixia Ding, Jun-Wei Lu, Jie Wang, Xiang Li, Yahua Zhong, Xiang Li · 2023 · Medicine
  87. Intracranial stimulation for brain cancer—The case for implantable, intracranial tumor treating fields
    David J. Segar, Joshua D. Bernstock, Sumientra M. Rampersad, Wenya Linda Bi, Omar M. Arnaout, Gregory K. Friedman, Ennio Antonio Chiocca · 2023 · Neuro-Oncology Advances
  88. Electric field distributions in realistic 3D rat head models during alternating electric field (AEF) therapy: a computational study
    Ha Nguyen, Keith Evan Schubert, Edwin Chang, Ying Nie, Christoph Pohling, Samuel Van Buskirk, Vicky N. Yamamoto, Yuping Zeng, Reinhard W. Schulte, Chirag B. Patel · 2023 · Physics in Medicine and Biology
  89. Preferred Imaging for Target Volume Delineation for Radiotherapy of Recurrent Glioblastoma: A Literature Review of the Available Evidence
    Francesco Cuccia, Fatemeh Jafari, Salvatore D’Alessandro, Giuseppe Carruba, Giuseppe Craparo, Giovanni Tringali, Livio Blasi, Giuseppe Ferrera · 2024 · Journal of Personalized Medicine
  90. Current status and research progress of minimally invasive treatment of glioma
    Hao Wu, Feng Zhou, Wenwen Gao, Peng Chen, Wei Yao, Fenglu Wang, Haikang Zhao · 2024 · Frontiers in Oncology
  91. Technical note: Computational study on thermal management schemes for tumor‐treating fields therapy
    Xin Yang, Chunhua Hu, Luming Li · 2024 · Medical Physics
  92. Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastoma
    Samuel Aaron Goldlust, Samuel Singer, Lori Cappello, Ahmad Kareem Almekkawi, Kangmin D. Lee, Anthony C. Ingenito, Brett E. Lewis, Themba L. Nyirenda, Hooman Azmi, George J. Kaptain · 2024 · Neuro-Oncology Advances
  93. The therapeutic efficacy and application prospects of tumor-treating fields (TTFields) in resolving malignant tumors of central nervous system
    Wei Han, Liang Chen · 2025 · Clinical & Translational Oncology
  94. Immune Modulation by Tumor-Derived Extracellular Vesicles in Glioblastoma
    Justin E. Hellwinkel, Helen J. Madsen, Michael W. Graner · 2015 · InTech eBooks
  95. Anticonvulsant therapy in brain-tumor related epilepsy
    W. Fröscher, Timo Kirschstein, Johannes Rösche · 2016 · Journal of Epileptology
  96. Quality of Life and Cognition
    Marijke B Coomans, Linda Dirven, MARTIN J.B. TAPHOORN · 2019 · Springer eBooks
  97. Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
    Stefanie Tietze, Susanne Michen, Gabriele Schackert, Achim Temme · 2021 · Innovative Surgical Sciences
  98. Application of the Taguchi method to explore a robust condition of tumor-treating field treatment
    K. Kurata, Kazuki Shimada, Hiroshi Takamatsu · 2022 · PLoS ONE
  99. Hypofractionated stereotactic radiotherapy combined with chemotherapy or not in the management of recurrent malignant gliomas: A systematic review and meta-analysis
    YJ Hu, Zhang Lf, Chang Ding, D Chen, Jing Chen · 2019 · Clinical Neurology and Neurosurgery
  100. Characteristics of sulfasalazine-induced cytotoxicity in C6 rat glioma cells
    Raffaela Silvestre Ignarro, Gustavo Facchini, Daniela Rodrigues de Melo, Karin Juliane Pelizzaro‐Rocha, Carmen Verı́ssima Ferreira, Roger Frigerio Castilho, Fábio Rogério · 2016 · Neuroscience Letters